3 Spectacular High-Yield Dividend Stocks to Buy
Discover how AbbVie investors that bought the anxiety over the loss of Humira exclusivity are sitting on massive gains. Read ...
However, arguably the next best thing is for a company to belong to the elite group known as Dividend Kings. To qualify, a ...
AbbVie reports disappointing mid-stage data for its schizophrenia drug. Jason Snipe of Odyssey Capital still likes AbbVie ...
AbbVie shares dropped nearly 10% after its schizophrenia drug emraclidine failed in late-stage trials. The market reaction ...
The added benefit is that AbbVie is a "Dividend King," which means it has consistently paid and increased dividends for ...
AbbVie Inc. (NYSE: ABBV) is rewarding its shareholders once again with a quarterly dividend of $1.55, payable on Tuesday Oct. 15th. While investors will wait to hear about quarterly earnings on ...
AbbVie (NYSE:ABBV) has once again raised its full-year outlook on soaring demand for its newer immunology medicines, Skyrizi ...
AbbVie (NYSE: ABBV) continues to demonstrate its prowess in navigating the challenging landscape of drug development and ...
Throw in a generous dividend payout that has more than tripled from that 2013 stock split and you have a blue-chip stock with a lot to offer in AbbVie. Tobacco giant Altria is the bluest of the ...